Fahd Al-Mulla, M.B.Ch.B, PCTM, FRCP, Ph.D.
Steering Committee, G2MC
- Professor of molecular pathology, Department of Clinical Pathology, Faculty of Medicine Kuwait University, Kuwait
- Head of functional genomics at Dasman Diabetes Institute, Kuwait
- Director, Genatak, a private sector center for Genomic Medicine, Kuwait
Dr. Al-Mulla is professor of molecular pathology and genomic medicine at Kuwait University and adjunct Faculty at Marshall University, Joan C. Edwards School of Medicine USA. Fahd is the founding director of Genatak, a center of genomic medicine, which aims at delivering state-of-the-art genomic services to the public and health services in the Middle East. His research addresses the challenges for translating genomic information into cancer diagnosis, prognosis and precision treatment.
Besides G2MC, Dr. Al-Mulla’s genomic medicine implementation projects include:
- Implementing genomic medicine practices in familial breast, colorectal and prostate cancer.
- Establishing the Arabian genome map. Collaborating with pharmaceutical industry for establishing novel treatments for cancer and metastasis.
